Statistics
Publications
114
Citations
9.9K
H-Index
50
Active since
1983
Eberhard Schulz is an author at Johannes Gutenberg University Mainz specializing in endothelial dysfunction, life sciences, and pharmacology.
Publications per year
1983–2023
114
114
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven, Matthias Oelze, Alina Hanf et al. · Redox Biology · 2017 · 305 citations · Full text
1–5 of 114